Levine DA - Search Results

1

Genetic analysis of the early natural history of epithelial ovarian carcinoma.

Pothuri B, Leitao MM, Levine DA, Viale A, Olshen AB, Arroyo C, Bogomolniy F, Olvera N, Lin O, Soslow RA, Robson ME, Offit K, Barakat RR, Boyd J. Pothuri B, et al. Among authors: levine da. PLoS One. 2010 Apr 26;5(4):e10358. doi: 10.1371/journal.pone.0010358. PLoS One. 2010. PMID: 20436685 Free PMC article.

2

The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series.

Levine DA, Boyd J. Levine DA, et al. Cancer Res. 2001 Feb 1;61(3):908-11. Cancer Res. 2001. PMID: 11221880 Review.

3

Risk of endometrial carcinoma associated with BRCA mutation.

Levine DA, Lin O, Barakat RR, Robson ME, McDermott D, Cohen L, Satagopan J, Offit K, Boyd J. Levine DA, et al. Gynecol Oncol. 2001 Mar;80(3):395-8. doi: 10.1006/gyno.2000.6082. Gynecol Oncol. 2001. PMID: 11263938

4

Cell proliferation and apoptosis in BRCA-associated hereditary ovarian cancer.

Levine DA, Federici MG, Reuter VE, Boyd J. Levine DA, et al. Gynecol Oncol. 2002 Jun;85(3):431-4. doi: 10.1006/gyno.2002.6646. Gynecol Oncol. 2002. PMID: 12051869

5

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.

Levine DA, Argenta PA, Yee CJ, Marshall DS, Olvera N, Bogomolniy F, Rahaman JA, Robson ME, Offit K, Barakat RR, Soslow RA, Boyd J. Levine DA, et al. J Clin Oncol. 2003 Nov 15;21(22):4222-7. doi: 10.1200/JCO.2003.04.131. J Clin Oncol. 2003. PMID: 14615451 Review.

6

Use of an ureteroileocecal appendicostomy urinary reservoir in patients with recurrent pelvic malignancies treated with radiation.

Bochner BH, McCreath WA, Aubey JJ, Levine DA, Barakat RR, Abu-Rustum N, Poynor E, Wong D, Chi DS. Bochner BH, et al. Among authors: levine da. Gynecol Oncol. 2004 Jul;94(1):140-6. doi: 10.1016/j.ygyno.2004.03.031. Gynecol Oncol. 2004. PMID: 15262132

7

Gastrointestinal adenocarcinoma arising in a mature cystic teratoma of the ovary.

Levine DA, Villella JA, Poynor EA, Soslow RA. Levine DA, et al. Gynecol Oncol. 2004 Aug;94(2):597-9. doi: 10.1016/j.ygyno.2004.05.045. Gynecol Oncol. 2004. PMID: 15297213

8

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

Chi DS, Franklin CC, Levine DA, Akselrod F, Sabbatini P, Jarnagin WR, DeMatteo R, Poynor EA, Abu-Rustum NR, Barakat RR. Chi DS, et al. Among authors: levine da. Gynecol Oncol. 2004 Sep;94(3):650-4. doi: 10.1016/j.ygyno.2004.01.029. Gynecol Oncol. 2004. PMID: 15350354

9

Gene expression signature with independent prognostic significance in epithelial ovarian cancer.

Spentzos D, Levine DA, Ramoni MF, Joseph M, Gu X, Boyd J, Libermann TA, Cannistra SA. Spentzos D, et al. Among authors: levine da. J Clin Oncol. 2004 Dec 1;22(23):4700-10. doi: 10.1200/JCO.2004.04.070. Epub 2004 Oct 25. J Clin Oncol. 2004. PMID: 15505275

10

The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.

Eitan R, Levine DA, Abu-Rustum N, Sonoda Y, Huh JN, Franklin CC, Stevens TA, Barakat RR, Chi DS. Eitan R, et al. Among authors: levine da. Cancer. 2005 Apr 1;103(7):1397-401. doi: 10.1002/cncr.20920. Cancer. 2005. PMID: 15726548 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

593 results

Search Page